Rocuronium Bromide ( DrugBank: Rocuronium )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 70 | Spinal stenosis | 1 |
70. Spinal stenosis
Clinical trials : 95 / Drugs : 169 - (DrugBank : 61) / Drug target genes : 68 - Drug target pathways : 90
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05619848 (ClinicalTrials.gov) | October 25, 2022 | 9/11/2022 | Effect of Paravertebral Muscle Fat Infiltration on Rocuronium Use in Lumbar Surgery | Effect of Paravertebral Muscle Fat Infiltration on Rocuronium Use in Lumbar Surgery | Spinal Stenosis Lumbar | Drug: Rocuronium Bromide | Zheng Guo | NULL | Completed | 18 Years | 65 Years | All | 87 | Early Phase 1 | China |